US Edition
WHO Expands Essential Medicines List with Key Diabetes and Cancer Drugs
3 Articles
3 Articles
WHO Expands Essential Medicines List with Key Diabetes and Cancer Drugs
The World Health Organization has included GLP-1 drugs for diabetes, treatments for cystic fibrosis, and key cancer therapies in its essential medicines list, aiming to improve access to costly drugs globally. The move could act as a catalyst for broader accessibility, especially in low-resource settings.
Treatment for cystic fibrosis added to Essential Medicines List by the World Health Organization: A victory for campaigners, though prices still ‘toxic’ | Medicines Law & Policy
The World Health Organization today announced it has added the cystic fibrosis combination treatment elexacaftor + tezacaftor + ivacaftor (brand name Trikafta) to its Model Lists of Essential Medicines (EML) and Essential Medicines for Children. This is a huge win for cystic fibrosis patients, and their parents, offering the possibility that access to this critical medicine – which has been difficult due to high prices and a lack of registration…
The United Nations agency has today announced the update of the lists of essential medicines for adults and children, in which new treatments have been added for various types of cancer and diabetes with associated comorbidities, such as obesity, but also for cystic fibrosis, psoriasis and blood-related diseases. These lists, according to WHO, include medicines for the primary health needs of populations and are adopted in more than 150 countrie…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
